Advertisement
Research Article| Volume 3, ISSUE 3, P228-237, July 2012

Patient characteristics associated with polypharmacy and inappropriate prescribing of medications among older adults with cancer

  • Gopi K. Prithviraj
    Affiliations
    Department of Medicine, University Hospitals Case Medical Center, Cleveland, OH, USA
    Search for articles by this author
  • Siran Koroukian
    Affiliations
    Case Comprehensive Cancer Center, Cleveland, OH, USA

    Department of Epidemiology and Biostatistics, Case Western Reserve School of Medicine, Cleveland, OH, USA
    Search for articles by this author
  • Seunghee Margevicius
    Affiliations
    Department of Epidemiology and Biostatistics, Case Western Reserve School of Medicine, Cleveland, OH, USA
    Search for articles by this author
  • Nathan A. Berger
    Affiliations
    Department of Medicine, University Hospitals Case Medical Center, Cleveland, OH, USA

    Case Comprehensive Cancer Center, Cleveland, OH, USA

    Division of Hematology/Oncology, University Hospitals Case Medical Center, Cleveland, OH, USA
    Search for articles by this author
  • Rakesh Bagai
    Affiliations
    Cleveland Clinic, Cleveland, OH, USA
    Search for articles by this author
  • Cynthia Owusu
    Correspondence
    Corresponding author at: Case Western Reserve University School of Medicine, UHHS Seidman Cancer Center-BHC 5055, 11100 Euclid Avenue, Cleveland, OH 44106–5055, USA. Tel.: +1 216 844 7670; fax: +1 216 844 5234.
    Affiliations
    Department of Medicine, University Hospitals Case Medical Center, Cleveland, OH, USA

    Case Comprehensive Cancer Center, Cleveland, OH, USA

    Division of Hematology/Oncology, University Hospitals Case Medical Center, Cleveland, OH, USA
    Search for articles by this author
Published:March 14, 2012DOI:https://doi.org/10.1016/j.jgo.2012.02.005

      Abstract

      Objectives

      To identify patient characteristics associated with polypharmacy and inappropriate medication (PIM) use among older patients with newly diagnosed cancer.

      Materials and Methods

      This is a cross-sectional study conducted in ambulatory oncology clinics at an academic center. Participants included 117 patients aged ≥65 years with newly diagnosed histologically confirmed stage I–IV cancer and were enrolled between April 2008 and September 2009. Medication review, included patient self-report and medical records. Polypharmacy was defined as the concurrent use of ≥five medications, (Yes/No). PIM use was defined as use of ≥one medication included in the 2003 update of Beers Criteria, (Yes/No).

      Results

      The prevalence of polypharmacy and PIM use was 80% and 41%, respectively. Three independent correlates of medication use were identified. An increase in comorbidity count by one, ECOG-PS score by one, and PIM use by one, was associated with an increase in medication use by 0.48 (P=0.0002), 0.79 (P=0.01) and 1.22 (P=0.006), respectively. Two independent correlates of PIM use were identified. The odds of using PIMs decreased by 10% for one unit increase in Body Mass Index [Odds Ratio (OR) 0.90, 95% CI=(0.84, 0.97)], and increased by 18% for each increase in medication count by one [OR 1.18, 95% CI=(1.04, 1.34)].

      Conclusion

      There was a high prevalence of polypharmacy and PIM use in older patients with newly diagnosed cancer. Given the co-occurrence of polypharmacy with poor performance status and multi-morbidity, multi-dimensional interventions are needed in the geriatric-oncology population to improve health and cancer outcomes.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Geriatric Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Steinman M.A.
        • Landefeld C.S.
        • Rosenthal G.E.
        • Berthenthal D.
        • Sen S.
        • Kaboli P.J.
        Polypharmacy and prescribing quality in older people.
        J Am Geriatr Soc. 2006 Oct; 54: 1516-1523
        • Fick D.M.
        • Cooper J.W.
        • Wade W.E.
        • Waller J.L.
        • Maclean J.R.
        • Beers M.H.
        Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts.
        Arch Intern Med. 2003 Dec 8–22; 163: 2716-2724
        • Beers M.H.
        Explicit criteria for determining potentially inappropriate medication use by the elderly. An update.
        Arch Intern Med. 1997 Jul 28; 157: 1531-1536
        • Beers M.H.
        • Ouslander J.G.
        • Rollingher I.
        • Reuben D.B.
        • Brooks J.
        • Beck J.C.
        Explicit criteria for determining inappropriate medication use in nursing home residents. UCLA Division of Geriatric Medicine.
        Arch Intern Med. 1991 Sep; 151: 1825-1832
        • Lichtman S.M.
        • Boparai M.K.
        Anticancer drug therapy in the older cancer patient: pharmacology and polypharmacy.
        Curr Treat Options Oncol. 2008 Jun; 9: 191-203
        • Hajjar E.R.
        • Cafiero A.C.
        • Hanlon J.T.
        Polypharmacy in elderly patients.
        Am J Geriatr Pharmacother. 2007 Dec; 5: 345-351
        • Lau D.T.
        • Kasper J.D.
        • Potter D.E.
        • Lyles A.
        • Bennett R.G.
        Hospitalization and death associated with potentially inappropriate medication prescriptions among elderly nursing home residents.
        Arch Intern Med. 2005 Jan 10; 165: 68-74
        • Hamilton H.J.
        • Gallagher P.F.
        • O'Mahony D.
        Inappropriate prescribing and adverse drug events in older people.
        BMC Geriatr. 2009; 9: 5
        • Ryan C.
        • O'Mahony D.
        • Kennedy J.
        • Weedle P.
        • Barry P.
        • Gallagher P.
        • et al.
        Appropriate prescribing in the elderly: an investigation of two screening tools, Beers criteria considering diagnosis and independent of diagnosis and improved prescribing in the elderly tool to identify inappropriate use of medicines in the elderly in primary care in Ireland.
        J Clin Pharm Ther. 2009 Aug; 34: 369-376
        • Hanlon J.T.
        • Fillenbaum G.G.
        • Kuchibhatla M.
        • Artz M.B.
        • Boult C.
        • Gross C.R.
        • et al.
        Impact of inappropriate drug use on mortality and functional status in representative community dwelling elders.
        Med Care. 2002 Feb; 40: 166-176
        • Agostini J.V.
        • Han L.
        • Tinetti M.E.
        The relationship between number of medications and weight loss or impaired balance in older adults.
        J Am Geriatr Soc. 2004 Oct; 52: 1719-1723
        • Weiner D.K.
        • Hanlon J.T.
        • Studenski S.A.
        Effects of central nervous system polypharmacy on falls liability in community-dwelling elderly.
        Gerontology. 1998; 44: 217-221
        • Field T.S.
        • Gurwitz J.H.
        • Avorn J.
        • McCormick D.
        • Jain S.
        • Eckler M.
        • et al.
        Risk factors for adverse drug events among nursing home residents.
        Arch Intern Med. 2001 Jul 9; 161: 1629-1634
        • Riechelmann R.P.
        • Tannock I.F.
        • Wang L.
        • Saad E.D.
        • Taback N.A.
        • Krzyzanowska M.K.
        Potential drug interactions and duplicate prescriptions among cancer patients.
        J Natl Cancer Inst. 2007 Apr 18; 99: 592-600
        • Flood K.L.
        • Carroll M.B.
        • Le C.V.
        • Brown C.J.
        Polypharmacy in hospitalized older adult cancer patients: experience from a prospective, observational study of an oncology-acute care for elders unit.
        Am J Geriatr Pharmacother. 2009 Jun; 7: 151-158
        • Maggiore R.J.
        • Gross C.P.
        • Hurria A.
        Polypharmacy in older adults with cancer.
        Oncologist. 2010; 15: 507-522
        • Tam-McDevitt J.
        Polypharmacy, aging, and cancer.
        Oncology. 2008 Aug;22; (Williston Park, NY.) (discussion 5, 8, 60): 1052-1055
        • Misra D.
        • Seo P.H.
        • Cohen H.J.
        Aging and cancer.
        Clin Adv Hematol Oncol. 2004 Jul; 2: 457-465
        • Corcoran M.E.
        Polypharmacy in the older patient with cancer.
        Cancer Control. 1997 Oct; 4: 419-428
        • Laroche M.L.
        • Charmes J.P.
        • Nouaille Y.
        • Picard N.
        • Merle L.
        Is inappropriate medication use a major cause of adverse drug reactions in the elderly?.
        Br J Clin Pharmacol. 2007 Feb; 63: 177-186
        • Fillenbaum G.G.
        • Hanlon J.T.
        • Landerman L.R.
        • Artz M.B.
        • O'Connor H.
        • Dowd B.
        • et al.
        Impact of inappropriate drug use on health services utilization among representative older community-dwelling residents.
        Am J Geriatr Pharmacother. 2004 Jun; 2: 92-101
        • Lund B.C.
        • Carnahan R.M.
        • Egge J.A.
        • Chrischilles E.A.
        • Kaboli P.J.
        Inappropriate prescribing predicts adverse drug events in older adults.
        Ann Pharmacother. 2010 Jun; 44: 957-963
        • Aparasu R.R.
        • Mort J.R.
        Inappropriate prescribing for the elderly: beers criteria-based review.
        Ann Pharmacother. 2000 Mar; 34: 338-346
        • Gallagher P.F.
        • Barry P.J.
        • Ryan C.
        • Hartigan I.
        • O'Mahony D.
        Inappropriate prescribing in an acutely ill population of elderly patients as determined by Beers' Criteria.
        Age Ageing. 2008 Jan; 37: 96-101
        • Chang C.M.
        • Liu P.Y.
        • Yang Y.H.
        • Yang Y.C.
        • Wu C.F.
        • Lu F.H.
        Use of the Beers criteria to predict adverse drug reactions among first-visit elderly outpatients.
        Pharmacotherapy. 2005 Jun; 25: 831-838
        • Chrischilles E.A.
        • VanGilder R.
        • Wright K.
        • Kelly M.
        • Wallace R.B.
        Inappropriate medication use as a risk factor for self-reported adverse drug effects in older adults.
        J Am Geriatr Soc. 2009 Jun; 57: 1000-1006
        • Sokol K.C.
        • Knudsen J.F.
        • Li M.M.
        Polypharmacy in older oncology patients and the need for an interdisciplinary approach to side-effect management.
        J Clin Pharm Ther. 2007 Apr; 32: 169-175
        • Haider S.I.
        • Johnell K.
        • Weitoft G.R.
        • Thorslund M.
        • Fastbom J.
        The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people.
        J Am Geriatr Soc. 2009 Jan; 57: 62-69
        • Linjakumpu T.
        • Hartikainen S.
        • Klaukka T.
        • Veijola J.
        • Kivela S.L.
        • Isoaho R.
        Use of medications and polypharmacy are increasing among the elderly.
        J Clin Epidemiol. 2002 Aug; 55: 809-817
        • Jorgensen T.
        • Johansson S.
        • Kennerfalk A.
        • Wallander M.A.
        • Svardsudd K.
        Prescription drug use, diagnoses, and healthcare utilization among the elderly.
        Ann Pharmacother. 2001 Sep; 35: 1004-1009
        • Charlson M.E.
        • Pompei P.
        • Ales K.L.
        • MacKenzie C.R.
        A new method of classifying prognostic comorbidity in longitudinal studies: development and validation.
        J Chronic Dis. 1987; 40: 373-383
        • Crum R.M.
        • Anthony J.C.
        • Bassett S.S.
        • Folstein M.F.
        Population-based norms for the Mini-Mental State Examination by age and educational level.
        JAMA. 1993 May 12; 269: 2386-2391
        • Sherbourne C.D.
        • Stewart A.L.
        The MOS social support survey.
        Soc Sci Med. 1991; 32: 705-714
        • Fulton M.M.
        • Allen E.R.
        Polypharmacy in the elderly: a literature review.
        J Am Acad Nurse Pract. 2005 Apr; 17: 123-132
        • Pugh M.J.
        • Palmer R.F.
        • Parchman M.L.
        • Mortensen E.
        • Markides K.
        • Espino D.V.
        Association of suboptimal prescribing and change in lower extremity physical function over time.
        Gerontology. 2007; 53: 445-453
        • Lai S.W.
        • Liao K.F.
        • Liao C.C.
        • Muo C.H.
        • Liu C.S.
        • Sung F.C.
        Polypharmacy correlates with increased risk for hip fracture in the elderly: a population-based study.
        Medicine. 2010 Sep; 89: 295-299
        • Gnjidic D.
        • Cumming R.G.
        • Le Couteur D.G.
        • Handelsman D.J.
        • Naganathan V.
        • Abernethy D.R.
        • et al.
        Drug Burden Index and physical function in older Australian men.
        Br J Clin Pharmacol. 2009 Jul; 68: 97-105
        • Lichtman S.M.
        Guidelines for the treatment of elderly cancer patients.
        Cancer Control. 2003 Nov-Dec; 10: 445-453
        • Fried L.P.
        • Tangen C.M.
        • Walston J.
        • Newman A.B.
        • Hirsch C.
        • Gottdiener J.
        • et al.
        Frailty in older adults: evidence for a phenotype.
        J Gerontol. 2001 Mar; 56: M146-M156
        • Tully C.L.
        • Snowdon D.A.
        Weight change and physical function in older women: findings from the Nun Study.
        J Am Geriatr Soc. 1995 Dec; 43: 1394-1397
        • Newman A.B.
        • Yanez D.
        • Harris T.
        • Duxbury A.
        • Enright P.L.
        • Fried L.P.
        Weight change in old age and its association with mortality.
        J Am Geriatr Soc. 2001 Oct; 49: 1309-1318
        • Halvorsen K.H.
        • Ruths S.
        • Granas A.G.
        • Viktil K.K.
        Multidisciplinary intervention to identify and resolve drug-related problems in Norwegian nursing homes.
        Scand J Prim Health Care. 2010 Jun; 28: 82-88
        • Denneboom W.
        • Dautzenberg M.G.
        • Grol R.
        • De Smet P.A.
        Analysis of polypharmacy in older patients in primary care using a multidisciplinary expert panel.
        Br J Gen Pract. 2006 Jul; 56: 504-510
        • Klopotowska J.E.
        • Wierenga P.C.
        • de Rooij S.E.
        • Stuijt C.C.
        • Arisz L.
        • Kuks P.F.
        • et al.
        The effect of an active on-ward participation of hospital pharmacists in Internal Medicine teams on preventable Adverse Drug Events in elderly inpatients: protocol of the WINGS study (Ward-oriented pharmacy In Newly admitted Geriatric Seniors).
        BMC Health Serv Res. 2011 May 25; 11: 124
        • Hanlon J.T.
        • Weinberger M.
        • Samsa G.P.
        • Schmader K.E.
        • Uttech K.M.
        • Lewis I.K.
        • et al.
        A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy.
        Am J Med. 1996 Apr; 100: 428-437
        • Cowper P.A.
        • Weinberger M.
        • Hanlon J.T.
        • Landsman P.B.
        • Samsa G.P.
        • Uttech K.M.
        The cost-effectiveness of a clinical pharmacist intervention among elderly outpatients.
        Pharmacotherapy. 1998 Mar-Apr; 18: 327-332